Targeted Therapies on the Rise: Global Cabozantinib Market Forecast to Nearly Double by 2032 View Full Report: https://dataintelo.com/report/global-cabozantinib-market The worldwide Cabozantinib Market is entering an accelerated growth phase, driven by expanded oncology approvals, precision‑medicine adoption, and heightened demand for orally administered tyrosine‑kinase inhibitors (TKIs). As oncologists seek effective options against advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer, cabozantinib is fast becoming a cornerstone therapy across multiple treatment lines.